Abstract Purpose This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. Principal results 92% of responding neurologists considered their NMO patients to be at an elevated risk of acquiring Covid19. They also indicated sharp declines in visits, delays in treatment and related services, and several unmet needs deterring treatment. Major conclusions There is a need for evidence-based, comprehensive guidelines for treating NMO patients amid healthcare crises moving forward.

中文翻译：

---

Covid19 环境中视神经脊髓炎的实践和处方变化：对神经病学家的调查

摘要目的本研究报告并分析了美国和加拿大的 192 名神经科医生对 2020 年 4 月分发的新调查工具的反应结果，以评估 Covid19 大流行期间 NMO 的做法和处方变化。主要结果 92% 做出回应的神经科医生认为他们的 NMO 患者感染 Covid19 的风险较高。他们还表示就诊人数急剧下降，治疗和相关服务出现延误，以及一些阻碍治疗的未满足需求。主要结论 在医疗危机不断推进的情况下，需要有基于证据的综合指南来治疗 NMO 患者。